That TTLL5 is not essential for survival also makes this protein an interesting candidate drug target to modulate its glutamylation activity to regulate and possibly even increase MT transport in neurodegenerative diseases where MT transport is known to be affected (Bodakuntla et al., 2020). This evidence concerns the gene TTLL5 and neurodegenerative disease.